Thyroid Hormones in Critical Illness.

Area of Science:

• Endocrinology
• Critical Care Medicine
• Molecular Biology

Background:

• Thyroid hormone is essential for metabolic regulation and normal physiological function.
• Circulating levels of the active thyroid hormone, triiodothyronine (T3), are often reduced in patients experiencing critical illness.
• The clinical significance of these reduced T3 levels—whether adaptive or detrimental—remains a subject of ongoing debate.

Purpose of the Study:

• To review the physiological basis for thyroid hormone alterations in critical illness.
• To evaluate the existing evidence on the role of T3 replacement therapy in managing critical illness.

Main Methods:

• Literature review of studies investigating thyroid hormone metabolism and function during critical illness.
• Analysis of clinical trial data and observational studies on T3 replacement strategies.

Main Results:

• The review synthesizes current understanding of the complex changes in thyroid hormone pathways during critical illness.
• Evidence regarding the efficacy and safety of T3 replacement in critical illness is critically assessed, highlighting areas of controversy and uncertainty.

Conclusions:

• Understanding the adaptive or maladaptive nature of thyroid hormone changes in critical illness is crucial.
• Further research is needed to clarify the precise role and optimal application of T3 replacement therapy in critical care settings.